Michael A. Byrne
Direttore Finanziario/CFO presso Viventia Biotech, Inc.
Profilo
Michael A.
Byrne is Chief Financial Officer and Corporate Secretary of Viventia Biotech, Inc. Prior to joining Viventia, he was Chief Financial Officer of Hyal Pharmaceuticals, Inc. Mr. Byrne has over 20 years of executive experience in the biotech and pharmaceutical sector.
Posizioni attive di Michael A. Byrne
Società | Posizione | Inizio |
---|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Direttore Finanziario/CFO | 01/01/2000 |
Precedenti posizioni note di Michael A. Byrne
Società | Posizione | Fine |
---|---|---|
Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Hyal Pharmaceutical Corp. | Health Technology |
- Borsa valori
- Insiders
- Michael A. Byrne